These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9327814)

  • 1. A controlled letter intervention to change prescribing behavior: results of a dual-targeted approach.
    Collins TM; Mott DA; Bigelow WE; Zimmerman DR
    Health Serv Res; 1997 Oct; 32(4):471-89. PubMed ID: 9327814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug utilization review of sedative/hypnotic agents in Texas Medicaid patients. Texas Medicaid Vendor Drug Program Drug Utilization Review Board.
    Seltzer JK; Kurt TL; Knodel LC; Dean B; Burch C
    J Am Pharm Assoc (Wash); 2000; 40(4):495-9. PubMed ID: 10932458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of targeting a DUR letter intervention at pharmacists separate from and in addition to physicians.
    Mott DA; Collins TM
    J Am Pharm Assoc (Wash); 1998; 38(3):325-32. PubMed ID: 9654863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a DUR intervention: a case study of histamine antagonists.
    Zimmerman DR; Collins TM; Lipowski EE; Sainfort F
    Inquiry; 1994; 31(1):89-101. PubMed ID: 7909535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of an educational intervention for secondary prevention of myocardial infarction on Medicaid drug use and cost.
    Zuckerman IH; Weiss SR; McNally D; Layne B; Mullins CD; Wang J
    Am J Manag Care; 2004 Jul; 10(7 Pt 2):493-500. PubMed ID: 15298236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacists' reactions to the Wisconsin Medicaid drug-use review program.
    Brown CM; Lipowski EE
    Am J Hosp Pharm; 1993 Sep; 50(9):1898-902. PubMed ID: 7907839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Washington State CARE Project: downstream cost changes associated with the provision of cognitive services by pharmacists.
    Smith DH; Fassett WE; Christensen DB
    J Am Pharm Assoc (Wash); 1999; 39(5):650-7. PubMed ID: 10533346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the impact of educational interventions on use of antithrombotics in Australia.
    Mandryk JA; Wai A; Mackson JM; Patterson C; Bhasale A; Weekes LM
    Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):160-71. PubMed ID: 18098333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of inappropriate drug prescribing by computerized, retrospective DUR screening in Korea.
    Yeom JH; Park JS; Oh OH; Shin HT; Oh JM
    Ann Pharmacother; 2005 Nov; 39(11):1918-23. PubMed ID: 16219902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
    Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
    Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polypharmacy management in Medicare managed care: changes in prescribing by primary care physicians resulting from a program promoting medication reviews.
    Fillit HM; Futterman R; Orland BI; Chim T; Susnow L; Picariello GP; Scheye EC; Spoeri RK; Roglieri JL; Warburton SW
    Am J Manag Care; 1999 May; 5(5):587-94. PubMed ID: 10537865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of anti-epileptic drugs in fee-for-service Wisconsin Medicaid.
    Mergener MA; Carr RM
    WMJ; 2006 Sep; 105(6):36-9. PubMed ID: 17042418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution.
    Mott DA; Cline RR
    Med Care; 2002 Aug; 40(8):662-74. PubMed ID: 12187180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a physician-focused educational intervention on medicaid children with asthma.
    Lee E; McNally DL; Zuckerman IH
    Ann Pharmacother; 2004 Jun; 38(6):961-6. PubMed ID: 15122003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining physicians' knowledge and attitudes when prescribing drugs to treat gastrointestinal disorders.
    Soons KR; Lynch T; Seagrave M; Rolley L
    Clin Perform Qual Health Care; 1997; 5(2):94-8. PubMed ID: 10167220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving prescribing in the elderly: a study in the long term care setting.
    Gill SS; Misiaszek BC; Brymer C
    Can J Clin Pharmacol; 2001; 8(2):78-83. PubMed ID: 11493935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of prescription charges on repeat prescribing in primary care.
    Bradley F; Elvey R; Ashcroft DM; Noyce P
    J Clin Pharm Ther; 2007 Jun; 32(3):269-75. PubMed ID: 17489879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An intervention to develop repeat prescribing in community pharmacy.
    Saastamoinen LK; Klaukka TJ; Ilomäki J; Enlund H
    J Clin Pharm Ther; 2009 Jun; 34(3):261-5. PubMed ID: 19646075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a retrospective drug utilization review on potentially inappropriate prescribing in the elderly.
    Starner CI; Norman SA; Reynolds RG; Gleason PP
    Am J Geriatr Pharmacother; 2009 Feb; 7(1):11-9. PubMed ID: 19281936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.